ENDOTRONIX
Endotronix is a developer of hemodynamic monitoring technologies to help detect worsening heart failure earlier than ever before. The company's platform includes a cloud-based disease management data system and outpatient hemodynamic management with a breakthrough implantable wireless pulmonary artery sensor for early detection of worsening heart failure. It was founded in 2007 and is based in Lisle, Illinois.
ENDOTRONIX
Industry:
Biotechnology Health Care Medical Medical Device Software Wireless
Founded:
2007-01-01
Address:
Lisle, Illinois, United States
Country:
United States
Website Url:
http://www.endotronix.com
Total Employee:
51+
Status:
Active
Contact:
+8772878954
Email Addresses:
[email protected]
Total Funding:
129.6 M USD
Technology used in webpage:
SPF LetsEncrypt Domain Not Resolving Amazon IPv6 Google Apps For Business ReCAPTCHA JsDelivr Microsoft Azure DNS Cloudflare JS
Similar Organizations
Edison Pharmaceuticals
Edison Pharmaceuticals develops medicines for the treatments of children and adults diagnosed with rare and neglected diseases.
EyeNetra
EyeNetra is a developer of an eye diagnostics platform used to measure the correction of users' vision through smartphone-based technology.
Ontera
Ontera develops a hand-held point of use diagnostic platform that examines DNA and RNA, and analytes from any life form.
Telcare
Telcare develops machine-2-machine cellular technology that wirelessly connects patients and physicians to cure chronic illnesses.
Unchained Labs
Unchained Labs is a developer of life science biologics tools designed to help researchers break free from tools that just don't cut it.
Current Advisors List
Current Employees Featured
Founder
Investors List
SV Health Investors
SV Health Investors investment in Series D - Endotronix
Lumira Ventures
Lumira Ventures investment in Series D - Endotronix
Aperture Venture Partners
Aperture Venture Partners investment in Series D - Endotronix
Wanxiang America Healthcare Investments Group
Wanxiang America Healthcare Investments Group investment in Series D - Endotronix
OSF Ventures
OSF Ventures investment in Series D - Endotronix
Bioventures Investors
Bioventures Investors investment in Series D - Endotronix
Life Sciences Partners
Life Sciences Partners investment in Series D - Endotronix
Skydeck
Skydeck investment in Series D - Endotronix
Seroba Life Sciences
Seroba Life Sciences investment in Series D - Endotronix
Silicon Valley Bank
Silicon Valley Bank investment in Debt Financing - Endotronix
Official Site Inspections
http://www.endotronix.com Semrush global rank: 5.14 M Semrush visits lastest month: 1.58 K
- Host name: 45.60.98.233
- IP address: 45.60.98.233
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Endotronix"
About Endotronix
Prior to Endotronix, she held senior leadership roles at Novocure (Global Sr. Director of Clinical Trials) and HeartWare, Inc (Senior Director of Clinical Operations), where she oversaw global …See details»
Endotronix - Crunchbase Company Profile & Funding
Endotronix may be growing as evidenced by their active pursuit of FDA approvals for their Cordella PA sensor system, which is a strong indicator of product development and potential …See details»
Endotronix Company Profile 2024: Valuation, Investors …
Endotronix General Information Description. Developer of proactive heart management tools designed to detect cardiac failure. The company's tools offer a patient management platform and a pulmonary artery pressure sensor that …See details»
Endotronix - LinkedIn
Endotronix, a digital health medtech company, is developing an integrated platform to provide comprehensive, reimbursable health management tools for patients suffering from advanced heart failure.See details»
Endotronix - Contacts, Employees, Board Members, Advisors
Organization. Endotronix . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. Highlights. Employee Profiles 9. Number of Board …See details»
Endotronix Company Profile - MedTech Innovator
Summary: Endotronix, Inc., a medical technology company, has developed an integrated platform to provide comprehensive, reimbursable health management innovations for patients suffering …See details»
EQT Life Sciences portfolio company Endotronix acquired by …
Aug 20, 2024 EQT Life Sciences was the lead investor in Endotronix’s series D Financing, investing from its LSP Health Economics Fund 2. Endotronix is a leader in heart failure …See details»
ENDOTRONIX Company Profile - Office Locations, Competitors
ENDOTRONIX has 5 employees at their 1 location and $125.85 m in total funding,. See insights on ENDOTRONIX including office locations, competitors, revenue, financials, executives, …See details»
Endotronix - Funding, Financials, Valuation & Investors - Crunchbase
Endotronix is funded by 12 investors. SV Health Investors and Lumira Ventures are the most recent investors. Endotronix has a post-money valuation in the range of $100M to $500M as of …See details»
Edwards Lifesciences Expands Structural Heart Portfolio With ...
Jul 24, 2024 Building on an investment made in 2016, Edwards has exercised its option to acquire Endotronix, a leader in heart failure (HF) management solutions. Many structural heart …See details»
Endotronix being acquired by California life sciences company - iBIO
Jul 25, 2024 “Endotronix’s acquisition by Edwards Lifesciences is a remarkable success story for Illinois’ life sciences ecosystem,” Conrad wrote in an iBio statement. “This acquisition not only …See details»
Careers - Endotronix
Endotronix, Inc. 1415 West Diehl Road Suite #500W Naperville, IL 60563. [email protected]. In the U.S., the Cordella™ PA Sensor System is Rx Only. CAUTION: Federal law restricts this …See details»
Illinois Endotronix Acquired by Edwards Lifesciences in Major ...
Jul 24, 2024 In a significant development for Illinois’ healthcare technology sector, Endotronix has been acquired by Edwards Lifesciences, a global leader in patient-focused innovations for …See details»
Endotronix Announces Development Agreement for a New …
Jul 19, 2022 Endotronix, Inc., a medical technology company, delivers an integrated platform that provides comprehensive, reimbursable health management innovations for patients …See details»
Endotronix Presents Positive PROACTIVE-HF Clinical Trial Results …
Mar 5, 2024 Endotronix innovates at the intersection of Medtech & Digital Health to improve care for people living with heart failure (HF). The comprehensive Cordella solution enables …See details»
Endotronix Receives FDA Premarket Approval of the Cordella™ PA …
Jun 24, 2024 Endotronix will launch Cordella in the U.S. later this year. The company also shared that they have submitted a dossier for CE Mark review and expect a decision on …See details»
News coverage, press releases, and media contact ... - Endotronix
Endotronix, Inc. 1415 West Diehl Road Suite #500W Naperville, IL 60563. [email protected]. In the U.S., the Cordella™ PA Sensor System is Rx Only. CAUTION: Federal law restricts this …See details»
Endotronix Announces FDA Approval for PROACTIVE-HF Pivotal …
LISLE, Ill., Jan. 5, 2022 /PRNewswire/ -- Endotronix, Inc., a digital health and medical technology company dedicated to advancing the treatment of heart failure (HF), today announced the U.S ...See details»
Clinical - Endotronix
Endotronix's comprehensive solution is backed by solid clinical evidence and is at the forefront of that shift with a best-in-class experience for patients and clinicians. – Liviu Klein, MD, …See details»